Citigroup have commented on the takeover offer by saying that a competing offer by another Chinese suitor cannot be ruled out. They point to the Chinese' clear appetite for foreign vitamins.
They also mention that the company has indicated there may be some slowing in Chinese demand and that VIT is still trading at a discount to Blackmore's. Price target lifts to $2.19 representing $2.25 T/O offer less 6 cents in dividends.
Ann: VIT enters into Scheme Implementation Deed-VIT.AX, page-178
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
